Genentech

ACTEMRA

View Prices
  1. Home
    2.  / 
  2. Q Code
    3.  / ACTEMRA – Q0249

Manufacturer:

Genentech

Name:

ACTEMRA

HCPCS Code Descriptor:

Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg

Category:

Q Code

HCPCS:

Q0249

NDC(s):

50242-0135-01, 50242-0136-01, 50242-0143-01, 50242-0138-01, 50242-0137-01

Primary Type:

COVID-19

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

ACTEMRA is a COVID-19 drug manufactured by Genentech and administered via the Intravenous route of administration. The Q Code: Q0249 is aligned to the drug ACTEMRA.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

6/24/21

HCPCS Effective Date:

6/24/21

HCPCS Short Description:

Tocilizumab for covid-19

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.gene.com/patients/patient-foundation